title: Effects of porcine growth hormone on glucose metabolism of pigs: II. Glucose tolerance, peripheral tissue insulin sensitivity and glucose kinetics.
abstract: This study was conducted to determine whether the increase in serum glucose observed in pigs treated chronically with pGH is due to an increase in hepatic glucose output or to an impairment in glucose clearance. Barrows (n = 4 per treatment) were treated with pituitary derived pGH (ppGH), recombinant pGH analog (rpGH) or vehicle. Pigs were treated for 28 d by daily i.m. injections. Insulin tolerance and glucose tolerance tests (GTT) were performed on d 19 and 21, respectively, following treatment with pGH. Glucose turnover was quantified on d 28 using [6-3H]glucose. Chronically treating pigs with pGH resulted in a significant decrease (26%; P less than .05) in glucose clearance, as determined by the GTT. Glucose clearance was affected similarly by ppGH and rpGH. Intra-arterial glucose infusion markedly increased plasma insulin concentration in pGH-treated pigs. Peak plasma insulin response was 87% and 58%, respectively, higher (P less than .05) in ppGH- and rpGH-treated than in control pigs. Insulin infusion elicited a marked hypoglycemia in pigs; however, the extent and duration of hypoglycemia were significantly less in pGH-treated pigs (ppGH or rpGH). Glucose production rates were 23% higher (P = .085) in ppGH-treated than in control pigs. These results establish that the hyperglycemia induced by pGH is the result of an increase in hepatic glucose output and a concurrent impairment in glucose clearance.
authors.affiliation: Dept. of Diary and Anim. Sci., Pennsylvania State University, University Park 16802.
authors.forename: R
authors.initials: R
authors.lastname: Gopinath
authors.forename: T D
authors.initials: TD
authors.lastname: Etherton
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D002406:Catheterization, Peripheral / Q000662:veterinary; D002408:Catheters, Indwelling; D005947:Glucose / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005951:Glucose Tolerance Test / Q000662:veterinary; D013006:Growth Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D007261:Infusions, Intra-Arterial / Q000662:veterinary; D007273:Injections, Intramuscular / Q000662:veterinary; D007328:Insulin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008297:Male; D011897:Random Allocation; D013552:Swine / Q000097:blood / Q000378:metabolism*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D013006:Growth Hormone; D005947:Glucose